Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension

Atherosclerosis

Volumn 216, Issue 1, 2011, Pages 199-204

  Salles, Gil F ^a   Cardoso, Claudia R L ^a   Fiszman, Roberto ^a   Muxfeldt, Elizabeth S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Hypertension; Microalbuminuria; Prognosis; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESISTANT HYPERTENSION; STROKE;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAZIL; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79955535485     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.026     Document Type: Article

References (27)

1. Valmadrid C.T., Klein R., Moss S.E., Klein B.E. The risk of cardiovascular disease mortality associated with albuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000, 160:1093-1100.
2. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997, 157:1413-1418.
3. Romundstad S., Holmen J., Kvenild K., Hallan H., Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag health study (HUNT), Norway. Am J Kidney Dis 2003, 42:466-473.
4. Yuyun M.F., Khaw K.-T., Luben R., et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population. Am J Epidemiol 2004, 159:284-293.
5. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
6. Cao J.J., Biggs M.L., Barzilay J., et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the cardiovascular health study. Atherosclerosis 2008, 197:806-813.
7. Gerstein H.C., Mann J.F., Yi Q., et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. J Am Med Assoc 2001, 286:421-426.
8. Jager A., Kostense P.J., Ruhé H.G., et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn study. Arterioscler Thromb Vasc Biol 1999, 19:617-624.
9. Jensen J.S., Feldt-Rasmussen B., Strandgaard S., Schroll M., Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000, 35:898-903.
10. Wachtell K., Ibsen H., Olsen M.H., et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003, 139:901-906.
11. Ruggenenti P., Remuzzi G. Time to abandon microalbuminuria?. Kidney Int 2006, 70:1214-1222.
12. Klausen K., Borch-Johnsen K., Feldt-Rasmussen B., et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004, 110:32-35.
13. Ärnlöv J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals. The Framingham heart study. Circulation 2005, 112:969-975.
14. Ibsen H., Olsen M.H., Wachtell K., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005, 45:198-202.
15. Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American heart association professional education committee of the council for high blood pressure research. Hypertension 2008, 51:1403-1419.
16. Redon J., Campos C., Narciso M.L., et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998, 31:712-718.
17. Salles G., Cardoso C., Muxfeldt E. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008, 168:2340-2346.
18. Muxfeldt E.S., Cardoso C.R.L., Salles G. Prognostic value of the nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 2009, 169:874-880.
19. Muxfeldt E.S., Bloch K.V., Nogueira A.R., Salles G.F. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003, 8:181-185.
20. Muxfeldt E.S., Bloch K.V., Nogueira Ada R., Salles G.F. True resistant hypertension: is it possible to be recognized in the office?. Am J Hypertens 2005, 18:1534-1540.
21. Weir M.R. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007, 2:581-590.
22. Klausen K.P., Scharling H., Jensen G., Appleyard M., Jensen J.S. New definition of microalbuminuria in hypertensive subjects. Association with incident coronary heart disease and death. Hypertension 2005, 46:33-37.
23. Redon J. Urinary albumin excretion. Lowering the threshold of risk in hypertension. Hypertension 2005, 46:19-20.
24. De Zeeuw D., Remuzzi G., Parving H.H., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110:921-927.
25. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989, 32:219-226.
26. Pontremoli R., Leoncini G., Viazzi F., et al. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. J Am Soc Nephrol 2006, 17:S112-S114.
27. Salles G.F., Fiszman R., Cardoso C.R., Muxfeldt E.S. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension 2007, 50:723-728.